Dr. Francisco A. Bonilla, MD

Dr. Bonilla practices at Northeast Allergy Asthma & Immunology in Leominster, Massachusetts.

Dr. Bonilla's NPI, 1245298215, was assigned on May 1, 2006. Dr. Bonilla graduated from Icahn School Of Medicine At Mount Sinai in 1990. Dr. Bonilla holds Massachusetts license 77974.

Dr. Bonilla's primary practice is Northeast Allergy Asthma & Immunology, at 79 Erdman Way, Leominster, MA 01453 in Worcester County. The practice phone is (978) 537-4805.

Dr. Bonilla's primary practice is Northeast Allergy Asthma & Immunology in Leominster, Massachusetts. Dr. Bonilla is also affiliated with Emerson Hospital. The medical group on file is Northeast Allergy, Asthma & Immunology. Dmand AI also links Dr. Bonilla to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bonilla practices, 4 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Bonilla's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Bonilla is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Bonilla's licenses on file in 2 states: Massachusetts and Florida.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, hives and immune deficiency disease among the conditions Dr. Bonilla treats.

CMS data shows 5,850 Medicare services from Dr. Bonilla across 11 procedure codes in 2024, for 326 Medicare patients. Medicare paid $61,958 for them. Every service was in an office.

CMS counts 326 Medicare patients who saw Dr. Bonilla in 2024. The largest group is 65 to 74, with 161 patients. 63% of them have high cholesterol, and 55% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bonilla's median patient age at 37, with 59% women.

In 2024, Dr. Bonilla wrote 886 Medicare Part D claims for 197 patients. 48% of them were for generic drugs. CMS names the drug for 706 of them, across 23 drugs with 11 or more claims each, at $488,131 in total drug cost. In 2023, CMS named 971 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Bonilla for performance year 2024, reported through an alternative payment model (APM). Dr. Bonilla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bonilla as offering telehealth.

Dmand AI links 87 papers to Dr. Bonilla, published from 2003 to 2023. 2016 was the busiest year, with 9. The most frequent topics are Immunologic Deficiency Syndromes, Agammaglobulinemia and Severe Combined Immunodeficiency. Dr. Bonilla has published most often in J Allergy Clin Immunol. Dr. Bonilla's most frequent co-authors are Luigi Notarangelo, MD, Hans D. Ochs and Jordan S. Orange, MD.

CMS Open Payments shows 556 general payments to Dr. Bonilla from 40 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 42% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $82,958. It also lists 1 research payment totaling $1,500 in 2023.

Dmand AI lists 2 awards for Dr. Bonilla.

Dr. Bonilla graduated from Icahn School Of Medicine At Mount Sinai in 1990. Dr. Bonilla is a member of AAAAI.

Dr. Bonilla is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.